HGF and plasma cell myeloma: The aim of this review is to summarize the key findings on the pathogenetic activity of HGF in multiple myeloma and further describe novel therapeutic approaches potentially helpful to overcome signals provided by the HGF/c-MET axis, putatively involved in drug resistance.